In a recent project, the Agency was asked to introduce an innovative new software solution, Organnect.ai, to the North American medical market. This Al-based solution was being developed by a Canadian medical technology company with the goal of improving and optimizing kidney transplantation and long-term graft survival.
Highlights of the undertaking consisted of all sales brochures, coordination of tradeshows, website development, social media, and investment brochures.
